AERI Stock, Aerie Pharmaceuticals Inc. Information
Stock Information
Get AERI Alerts
News, Short Squeeze, Breakout and More Instantly...
About Aerie Pharmaceuticals Inc.
Aerie Pharmaceuticals Inc is a clinical-stage pharmaceutical company. It is focused on the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, ocular surface diseases, and retinal diseases. Its main products are Rhopressa and Roklatan. The company mainly operates in North America.